Table 1.
Characteristics | Total | 2019 (n=752) | 2020 (n=704) | P† | |||||
---|---|---|---|---|---|---|---|---|---|
n (median) | % (IQR‡) | n (median) | % (IQR) | n (median) | % (IQR) | ||||
Age (yr) | 67 | 59~75 | 67 | 58~74 | 67 | 59~75 | 0.346 | ||
≥60 | 1057 | 72.6 | 534 | 71.0 | 523 | 74.3 | 0.161 | ||
<60 | 399 | 27.4 | 218 | 29.0 | 181 | 25.7 | |||
Sex | |||||||||
Male | 910 | 62.5 | 468 | 62.2 | 442 | 62.8 | 0.828 | ||
Female | 546 | 37.5 | 284 | 37.8 | 262 | 37.2 | |||
Insurance | |||||||||
National insurance | 1358 | 93.3 | 692 | 92.0 | 666 | 94.6 | <0.001 | ||
Medical aid | 59 | 4.1 | 26 | 3.5 | 33 | 4.7 | |||
Foreigner (no insurance) | 39 | 2.6 | 34 | 4.5 | 5 | 0.7 | |||
Residence | |||||||||
Metropolitan | 943 | 64.8 | 500 | 66.5 | 443 | 62.9 | 0.155 | ||
Non-metropolitan | 513 | 35.2 | 252 | 33.5 | 261 | 37.1 | |||
Cancer subtypes | |||||||||
Lip, oral cavity, and pharynx | 31 | 2.1 | 25 | 3.3 | 6 | 0.9 | 0.016 | ||
Gastrointestinal | 168 | 11.5 | 79 | 10.5 | 89 | 12.6 | |||
Hepatobiliary-pancreas | 447 | 30.7 | 223 | 29.7 | 224 | 31.8 | |||
Lung and intrathoracic | 259 | 17.8 | 140 | 18.6 | 119 | 16.9 | |||
Bone and soft tissue | 45 | 3.1 | 23 | 3.1 | 22 | 3.1 | |||
Breast | 77 | 5.3 | 49 | 6.5 | 28 | 4.0 | |||
Gynecological | 51 | 3.5 | 22 | 2.9 | 29 | 4.1 | |||
Genitourinary | 68 | 4.7 | 35 | 4.7 | 33 | 4.7 | |||
Hematological | 252 | 17.3 | 123 | 16.4 | 129 | 18.3 | |||
Other* | 58 | 4.0 | 33 | 4.4 | 25 | 3.6 | |||
Disease status at death | |||||||||
Recurrent or metastatic disease | 1170 | 80.4 | 620 | 82.5 | 550 | 78.1 | 0.038 | ||
Non-metastatic disease | 286 | 19.7 | 132 | 17.5 | 154 | 21.9 | |||
Medical division | |||||||||
Medical department | 1045 | 71.8 | 566 | 75.3 | 479 | 68.5 | 0.006 | ||
Surgical department | 135 | 9.2 | 57 | 7.6 | 78 | 11.1 | |||
Emergency medicine | 276 | 19.0 | 129 | 17.1 | 147 | 20.9 | |||
Length of hospital stay (last hospital visit) | |||||||||
Overall | 13 | 4~28 | 13 | 4~27.5 | 13 | 4~28 | 0.784 | ||
General ward | 16 | 8~31 | 15 | 7~31 | 17 | 8~31 | 0.224 | ||
ICU | 12 | 3~28 | 10 | 2~24 | 17 | 4~35 | 0.011 | ||
ER | 1 | 0~1 | 0 | 0~1 | 1 | 0~1 | 0.036 |
*“Other” includes malignant neoplasms of the skin (C43, C44), central nervous system (C69~C72), endocrine glands (C73~C75), and metastatic or unknown origin (C76~C80).
†The Student t-test was used for continuous variables and the chi-square test for categorical variables. The Mann-Whitney U test and the Fisher exact test were performed as non-parametric tests for continuous and categorical variables, respectively.
‡IQR indicates the difference between the 75th and 25th percentiles of the data (the lower quartile-the upper quartile).
IQR: interquartile range, ICU: intensive care unit, ER: emergency room.